trichostatin A

Trichostatin is a lipid of Polyketides (PK) class. Trichostatin is associated with abnormalities such as Dentatorubral-Pallidoluysian Atrophy, PARAGANGLIOMAS 3, abnormal fragmented structure, Disintegration (morphologic abnormality) and Hyperostosis, Diffuse Idiopathic Skeletal. The involved functions are known as Acetylation, Cell Differentiation process, histone modification, Gene Silencing and Transcriptional Activation. Trichostatin often locates in CD41a, Hematopoietic System, Chromatin Structure, Blood and Endothelium. The associated genes with Trichostatin are SPI1 gene, CELL Gene, Chromatin, CXCR4 gene and DNMT1 gene. The related lipids are Butyrates, Promega, butyrate, Lipopolysaccharides and Steroids. The related experimental models are Knock-out, Mouse Model, Xenograft Model and Cancer Model.

Cross Reference

Introduction

To understand associated biological information of trichostatin A, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with trichostatin A?

trichostatin A is suspected in Infection, Morphologically altered structure, Ureteral obstruction, Photosensitization, Atherosclerosis, Hypertrophic Cardiomyopathy and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with trichostatin A

MeSH term MeSH ID Detail
Goldenhar Syndrome D006053 1 associated lipids
Lymphoma, Follicular D008224 3 associated lipids
Supratentorial Neoplasms D015173 1 associated lipids
Myopathy, Central Core D020512 1 associated lipids
Rhabdomyosarcoma, Alveolar D018232 2 associated lipids
Rhabdomyosarcoma, Embryonal D018233 1 associated lipids
Rhabdoid Tumor D018335 1 associated lipids
Rubinstein-Taybi Syndrome D012415 1 associated lipids
Adenomyosis D062788 1 associated lipids
Lymphoma, Large-Cell, Anaplastic D017728 3 associated lipids
Per page 10 20 50 100 | Total 139

PubChem Associated disorders and diseases

What pathways are associated with trichostatin A

Lipid pathways are not clear in current pathway databases. We organized associated pathways with trichostatin A through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with trichostatin A?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with trichostatin A?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with trichostatin A?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with trichostatin A?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with trichostatin A?

Mouse Model

Mouse Model are used in the study 'Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer.' (Majid S et al., 2010), Mouse Model are used in the study 'Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy.' (Fang MZ et al., 2005) and Mouse Model are used in the study 'Histone deacetylase 3 mediates allergic skin inflammation by regulating expression of MCP1 protein.' (Kim Y et al., 2012).

Xenograft Model

Xenograft Model are used in the study 'Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma.' (Landreville S et al., 2012), Xenograft Model are used in the study 'Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells.' (Moiseeva EP et al., 2007) and Xenograft Model are used in the study 'Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model.' (Touma SE et al., 2005).

Cancer Model

Cancer Model are used in the study 'Plasma pharmacokinetics and metabolism of the histone deacetylase inhibitor trichostatin a after intraperitoneal administration to mice.' (Sanderson L et al., 2004).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with trichostatin A

Download all related citations
Per page 10 20 50 100 | Total 3126
Authors Title Published Journal PubMed Link
Kim HR et al. Trichostatin A induces apoptosis in lung cancer cells via simultaneous activation of the death receptor-mediated and mitochondrial pathway? 2006 Exp. Mol. Med. pmid:17202837
McCool KW et al. The role of histone acetylation in regulating early gene expression patterns during early embryonic stem cell differentiation. 2007 J. Biol. Chem. pmid:17204470
Bártová E et al. Differentiation-specific association of HP1alpha and HP1beta with chromocentres is correlated with clustering of TIF1beta at these sites. 2007 Histochem. Cell Biol. pmid:17205308
Kuang PP et al. Activation of elastin transcription by transforming growth factor-beta in human lung fibroblasts. 2007 Am. J. Physiol. Lung Cell Mol. Physiol. pmid:17209135
Cras A et al. Epigenetic patterns of the retinoic acid receptor beta2 promoter in retinoic acid-resistant thyroid cancer cells. 2007 Oncogene pmid:17213810
Karagiannis TC et al. Disparity of histone deacetylase inhibition on repair of radiation-induced DNA damage on euchromatin and constitutive heterochromatin compartments. 2007 Oncogene pmid:17213813
Elaut G et al. A metabolic screening study of trichostatin A (TSA) and TSA-like histone deacetylase inhibitors in rat and human primary hepatocyte cultures. 2007 J. Pharmacol. Exp. Ther. pmid:17218485
Kozłowska A and Jagodziński PP Effect of Trichostatin A on CD4 surface density in peripheral blood T cells. 2006 Folia Histochem. Cytobiol. pmid:17219719
He J et al. Effects of trichostatin A on HDAC8 expression, proliferation and cell cycle of Molt-4 cells. 2006 J. Huazhong Univ. Sci. Technol. Med. Sci. pmid:17219959
Liu H et al. Trichostatin A regulates hGCN5 expression and cell cycle on Daudi cells in vitro. 2006 J. Huazhong Univ. Sci. Technol. Med. Sci. pmid:17219960
Sun C et al. Anticancer activities of trichostatin A on maligant lymphoid cells. 2006 J. Huazhong Univ. Sci. Technol. Med. Sci. pmid:17219961
Ting CH et al. Stat5 constitutive activation rescues defects in spinal muscular atrophy. 2007 Hum. Mol. Genet. pmid:17220171
Feng W et al. Multiple histone deacetylases repress tumor suppressor gene ARHI in breast cancer. 2007 Int. J. Cancer pmid:17230502
Karam JA et al. The use of histone deacetylase inhibitor FK228 and DNA hypomethylation agent 5-azacytidine in human bladder cancer therapy. 2007 Int. J. Cancer pmid:17230511
Ghosh AK et al. Trichostatin A blocks TGF-beta-induced collagen gene expression in skin fibroblasts: involvement of Sp1. 2007 Biochem. Biophys. Res. Commun. pmid:17234156
Li Y et al. Regulation of neuronal nitric oxide synthase exon 1f gene expression by nuclear factor-kappaB acetylation in human neuroblastoma cells. 2007 J. Neurochem. pmid:17250678
Suzuki T et al. Identification of a potent and stable antiproliferative agent by the prodrug formation of a thiolate histone deacetylase inhibitor. 2007 Bioorg. Med. Chem. Lett. pmid:17257837
Scott SA et al. Zebularine inhibits human acute myeloid leukemia cell growth in vitro in association with p15INK4B demethylation and reexpression. 2007 Exp. Hematol. pmid:17258075
Ishihara K et al. Differentiation of eosinophilic leukemia EoL-1 cells into eosinophils induced by histone deacetylase inhibitors. 2007 Life Sci. pmid:17258775
Janowski BA et al. Activating gene expression in mammalian cells with promoter-targeted duplex RNAs. 2007 Nat. Chem. Biol. pmid:17259978
Oyama T et al. Cardiac side population cells have a potential to migrate and differentiate into cardiomyocytes in vitro and in vivo. 2007 J. Cell Biol. pmid:17261849
Nagashima T et al. Histone acetylation and subcellular localization of chromosomal protein BRD4 during mouse oocyte meiosis and mitosis. 2007 Mol. Hum. Reprod. pmid:17267518
Sakuma M et al. Promoter methylation status of the Cyclin D2 gene is associated with poor prognosis in human epithelial ovarian cancer. 2007 Cancer Sci. pmid:17270028
Han S et al. HDAC inhibitors TSA and sodium butyrate enhanced the human IL-5 expression by altering histone acetylation status at its promoter region. 2007 Immunol. Lett. pmid:17270283
Kim SH et al. Regulation of the HIF-1alpha stability by histone deacetylases. 2007 Oncol. Rep. pmid:17273746
Sugita K et al. Morphological reversion of sis-transformed NIH3T3 cells by trichostatin A. 1992 Cancer Res. pmid:1727377
Ou JN et al. Histone deacetylase inhibitor Trichostatin A induces global and gene-specific DNA demethylation in human cancer cell lines. 2007 Biochem. Pharmacol. pmid:17276411
Wu Y and Guo SW Suppression of IL-1beta-induced COX-2 expression by trichostatin A (TSA) in human endometrial stromal cells. 2007 Eur. J. Obstet. Gynecol. Reprod. Biol. pmid:17296257
Appanah R et al. An unmethylated 3' promoter-proximal region is required for efficient transcription initiation. 2007 PLoS Genet. pmid:17305432
Bui HT et al. Regulation of chromatin and chromosome morphology by histone H3 modifications in pig oocytes. 2007 Reproduction pmid:17307905
Yang QC et al. Inhibition of hypoxia-induced angiogenesis by trichostatin A via suppression of HIF-1a activity in human osteosarcoma. 2006 J. Exp. Clin. Cancer Res. pmid:17310851
Mayo C et al. In vitro differentiation of HT-29 M6 mucus-secreting colon cancer cells involves a trychostatin A and p27(KIP1)-inducible transcriptional program of gene expression. 2007 J. Cell. Physiol. pmid:17311291
Sugita K et al. A novel compound, depudecin, induces production of transformation to the flat phenotype of NIH3T3 cells transformed by ras-oncogene. 1992 Biochem. Biophys. Res. Commun. pmid:1731795
Avila AM et al. Trichostatin A increases SMN expression and survival in a mouse model of spinal muscular atrophy. 2007 J. Clin. Invest. pmid:17318264
Di Renzo F et al. Boric acid inhibits embryonic histone deacetylases: a suggested mechanism to explain boric acid-related teratogenicity. 2007 Toxicol. Appl. Pharmacol. pmid:17320131
Xin C et al. FTY720 suppresses interleukin-1beta-induced secretory phospholipase A2 expression in renal mesangial cells by a transcriptional mechanism. 2007 Br. J. Pharmacol. pmid:17325654
Putignano E et al. Developmental downregulation of histone posttranslational modifications regulates visual cortical plasticity. 2007 Neuron pmid:17329213
Vibhakar R et al. Dickkopf-1 is an epigenetically silenced candidate tumor suppressor gene in medulloblastoma. 2007 Neuro-oncology pmid:17329407
Pan L et al. Histone deacetylase inhibitor trichostatin a potentiates doxorubicin-induced apoptosis by up-regulating PTEN expression. 2007 Cancer pmid:17330857
Stiehl DP et al. Histone deacetylase inhibitors synergize p300 autoacetylation that regulates its transactivation activity and complex formation. 2007 Cancer Res. pmid:17332356
Jung J and Bonini N CREB-binding protein modulates repeat instability in a Drosophila model for polyQ disease. 2007 Science pmid:17332375
Jaffe RC et al. Histone deacetylase inhibition and progesterone act synergistically to stimulate baboon glycodelin gene expression. 2007 J. Mol. Endocrinol. pmid:17339403
Alimirah F et al. IFI16 in human prostate cancer. 2007 Mol. Cancer Res. pmid:17339605
Vikhanskaya F et al. Cancer-derived p53 mutants suppress p53-target gene expression--potential mechanism for gain of function of mutant p53. 2007 Nucleic Acids Res. pmid:17344317
Krennhrubec K et al. Design and evaluation of 'Linkerless' hydroxamic acids as selective HDAC8 inhibitors. 2007 Bioorg. Med. Chem. Lett. pmid:17346959
Hattori N et al. Epigenetic regulation of Nanog gene in embryonic stem and trophoblast stem cells. 2007 Genes Cells pmid:17352742
Barr H et al. Mbd2 contributes to DNA methylation-directed repression of the Xist gene. 2007 Mol. Cell. Biol. pmid:17353271
Li B et al. FOXP3 interactions with histone acetyltransferase and class II histone deacetylases are required for repression. 2007 Proc. Natl. Acad. Sci. U.S.A. pmid:17360565
Hashii M et al. Up-regulation of ras-GAP genes is reversed by a MEK inhibitor and doxorubicin in v-Ki-ras-transformed NIH/3T3 fibroblasts. 2007 Biochem. Biophys. Res. Commun. pmid:17367762
Hosseinkhani M et al. Trichostatin A induces myocardial differentiation of monkey ES cells. 2007 Biochem. Biophys. Res. Commun. pmid:17368572
Kim HJ et al. Histone deacetylase inhibitors exhibit anti-inflammatory and neuroprotective effects in a rat permanent ischemic model of stroke: multiple mechanisms of action. 2007 J. Pharmacol. Exp. Ther. pmid:17371805
Hummel M et al. Transcriptional reactivation of murine cytomegalovirus ie gene expression by 5-aza-2'-deoxycytidine and trichostatin A in latently infected cells despite lack of methylation of the major immediate-early promoter. 2007 J. Gen. Virol. pmid:17374752
Wu Y and Guo SW Histone deacetylase inhibitors trichostatin A and valproic acid induce cell cycle arrest and p21 expression in immortalized human endometrial stromal cells. 2008 Eur. J. Obstet. Gynecol. Reprod. Biol. pmid:17376583
Vandergeeten C et al. HIV-1 protease inhibitors do not interfere with provirus transcription and host cell apoptosis induced by combined treatment TNF-alpha + TSA. 2007 Biochem. Pharmacol. pmid:17386923
Rohner A et al. Differentiation-promoting drugs up-regulate NKG2D ligand expression and enhance the susceptibility of acute myeloid leukemia cells to natural killer cell-mediated lysis. 2007 Leuk. Res. pmid:17391757
Dompierre JP et al. Histone deacetylase 6 inhibition compensates for the transport deficit in Huntington's disease by increasing tubulin acetylation. 2007 J. Neurosci. pmid:17392473
Cao D et al. COX-2 expression induced by diesel particles involves chromatin modification and degradation of HDAC1. 2007 Am. J. Respir. Cell Mol. Biol. pmid:17395887
Seo H et al. An ex vivo method for rapid generation of monoclonal antibodies (ADLib system). 2006 Nat Protoc pmid:17406441
Snykers S et al. Chromatin remodeling agent trichostatin A: a key-factor in the hepatic differentiation of human mesenchymal stem cells derived of adult bone marrow. 2007 BMC Dev. Biol. pmid:17407549
Horion J et al. Histone deacetylase inhibitor trichostatin A sustains sodium pervanadate-induced NF-kappaB activation by delaying IkappaBalpha mRNA resynthesis: comparison with tumor necrosis factor alpha. 2007 J. Biol. Chem. pmid:17409387
Ryningen A et al. Clonogenic acute myelogenous leukemia cells are heterogeneous with regard to regulation of differentiation and effect of epigenetic pharmacological targeting. 2007 Leuk. Res. pmid:17416413
Chen Y et al. Homeobox gene HOP has a potential tumor suppressive activity in human lung cancer. 2007 Int. J. Cancer pmid:17417779
Liu T et al. Design and synthesis of a potent histone deacetylase inhibitor. 2007 J. Med. Chem. pmid:17419603
De los Santos M et al. Combined effects of retinoic acid and histone deacetylase inhibitors on human neuroblastoma SH-SY5Y cells. 2007 Mol. Cancer Ther. pmid:17431121
Hatjiharissi E et al. Proteomic analysis of waldenstrom macroglobulinemia. 2007 Cancer Res. pmid:17440091
Cecconi D et al. Proteomic analysis of pancreatic endocrine tumor cell lines treated with the histone deacetylase inhibitor trichostatin A. 2007 Proteomics pmid:17443844
Higashi T et al. Histone H2A mobility is regulated by its tails and acetylation of core histone tails. 2007 Biochem. Biophys. Res. Commun. pmid:17445770
Hwang CK et al. Evidence of endogenous mu opioid receptor regulation by epigenetic control of the promoters. 2007 Mol. Cell. Biol. pmid:17452465
[Isolation of drug-resistant mutant cells]. 1991 Tanpakushitsu Kakusan Koso pmid:1745788
Yi T et al. Trichostatin A-mediated upregulation of p21(WAF1) contributes to osteoclast apoptosis. 2007 Exp. Mol. Med. pmid:17464183
Wong CM et al. Tissue factor pathway inhibitor-2 as a frequently silenced tumor suppressor gene in hepatocellular carcinoma. 2007 Hepatology pmid:17464989
Vincent A et al. Epigenetic regulation (DNA methylation, histone modifications) of the 11p15 mucin genes (MUC2, MUC5AC, MUC5B, MUC6) in epithelial cancer cells. 2007 Oncogene pmid:17471237
Zhang C et al. Transcriptional silencing of the TMS1/ASC tumour suppressor gene by an epigenetic mechanism in hepatocellular carcinoma cells. 2007 J. Pathol. pmid:17471463
Gensert JM et al. CD81, a cell cycle regulator, is a novel target for histone deacetylase inhibition in glioma cells. 2007 Neurobiol. Dis. pmid:17481908
Hellebrekers DM et al. Identification of epigenetically silenced genes in tumor endothelial cells. 2007 Cancer Res. pmid:17483324
Piotrowska H and Jagodzinski PP Trichostatin A, sodium butyrate, and 5-aza-2'-deoxycytidine alter the expression of glucocorticoid receptor alpha and beta isoforms in Hut-78 T- and Raji B-lymphoma cell lines. 2007 Biomed. Pharmacother. pmid:17498915
Iliopoulos D et al. Epigenetic regulation of leptin affects MMP-13 expression in osteoarthritic chondrocytes: possible molecular target for osteoarthritis therapeutic intervention. 2007 Ann. Rheum. Dis. pmid:17502362
Choy SW et al. C. elegans SIN-3 and its associated HDAC corepressor complex act as mediators of male sensory ray development. 2007 Biochem. Biophys. Res. Commun. pmid:17506990
Royo H et al. Bsr, a nuclear-retained RNA with monoallelic expression. 2007 Mol. Biol. Cell pmid:17507654
de Boer J et al. Inhibition of histone acetylation as a tool in bone tissue engineering. 2006 Tissue Eng. pmid:17518660
Turaga RV et al. Werner syndrome protein prevents DNA breaks upon chromatin structure alteration. 2007 Aging Cell pmid:17521388
Wu J et al. Diverse histone modifications on histone 3 lysine 9 and their relation to DNA methylation in specifying gene silencing. 2007 BMC Genomics pmid:17524140
Schwechter BR et al. Histone deacetylase inhibition-mediated differentiation of RGC-5 cells and interaction with survival. 2007 Invest. Ophthalmol. Vis. Sci. pmid:17525221
Fan J et al. [Expression of ER alpha in chemically induced MDA-MB-435 cells and its responsiveness to endocrine]. 2006 Zhonghua Zhong Liu Za Zhi pmid:17533736
Kaneko M et al. Mechanism for the differentiation of EoL-1 cells into eosinophils by histone deacetylase inhibitors. 2007 Int. Arch. Allergy Immunol. pmid:17541273
Vecsey CG et al. Histone deacetylase inhibitors enhance memory and synaptic plasticity via CREB:CBP-dependent transcriptional activation. 2007 J. Neurosci. pmid:17553985
Pinnoji RC et al. Repressor element-1 silencing transcription factor/neuronal restrictive silencer factor (REST/NRSF) can regulate HSV-1 immediate-early transcription via histone modification. 2007 Virol. J. pmid:17555596
Khan Z et al. HDAC inhibition amplifies gap junction communication in neural progenitors: potential for cell-mediated enzyme prodrug therapy. 2007 Exp. Cell Res. pmid:17555745
Donadelli M et al. Synergistic inhibition of pancreatic adenocarcinoma cell growth by trichostatin A and gemcitabine. 2007 Biochim. Biophys. Acta pmid:17555830
Smetana K et al. Effect of histone deacetylase inhibitors on the cell nucleus and nucleolus of leukemic myeloblasts in vitro - a cytochemical study. 2007 Acta Histochem. pmid:17559910
Lin T et al. Histone deacetylase as therapeutic target in a rodent model of hemorrhagic shock: effect of different resuscitation strategies on lung and liver. 2007 Surgery pmid:17560255
Bai L and Merchant JL ATM phosphorylates ZBP-89 at Ser202 to potentiate p21waf1 induction by butyrate. 2007 Biochem. Biophys. Res. Commun. pmid:17560543
Rigamonti D et al. Loss of huntingtin function complemented by small molecules acting as repressor element 1/neuron restrictive silencer element silencer modulators. 2007 J. Biol. Chem. pmid:17565993
Kitamura H et al. Down-regulation of HLA class I antigens in prostate cancer tissues and up-regulation by histone deacetylase inhibition. 2007 J. Urol. pmid:17574613
Haffner I et al. Regulation of arginase-1 expression in macrophages by a protein kinase A type I and histone deacetylase dependent pathway. 2008 J. Cell. Biochem. pmid:17577214
Huang JC et al. Changes in histone acetylation during postovulatory aging of mouse oocyte. 2007 Biol. Reprod. pmid:17582009
Lee S et al. Design, synthesis, and evaluation of isoindolinone-hydroxamic acid derivatives as histone deacetylase (HDAC) inhibitors. 2007 Bioorg. Med. Chem. Lett. pmid:17588744
Castro-Galache MD et al. Protein kinase C-alpha antagonizes apoptosis induction by histone deacetylase inhibitors in multidrug resistant leukaemia cells. 2007 Int. J. Biochem. Cell Biol. pmid:17588800
Ye J et al. De novo protein synthesis is required for lytic cycle reactivation of Epstein-Barr virus, but not Kaposi's sarcoma-associated herpesvirus, in response to histone deacetylase inhibitors and protein kinase C agonists. 2007 J. Virol. pmid:17596302
Tuncel M et al. The comparative effects of gene modulators on thyroid-specific genes and radioiodine uptake. 2007 Cancer Biother. Radiopharm. pmid:17600477